A Phase 3 Randomized, Placebo-Controlled, Double-Blind Study to Evaluate Upadacitinib in Adolescent and Adult Subjects with Moderate to Severe Atopic Dermatitis

Project: Research

Status	Active
Effective start/end date	15/07/20 → 14/07/25

Project Details